학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 39건 | 목록 1~20
Academic Journal
Graff SL; Brown University Health Cancer Institute, Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.; Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Hart LL; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, Florida, USA.; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.; Razavi P; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Schwartzberg LS; Renown Health-William N. Pennington Cancer Institute, Reno, Nevada, USA.; Danyliv A; Novartis Pharma AG, Basel, Switzerland.; Akdere M; Novartis Pharma AG, Basel, Switzerland.; Ferrusi I; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Adhikary RR; Novartis Healthcare Pvt., Ltd, Hyderabad, Telangana, India.; O'Shaughnessy JA; Texas Oncology/Baylor University Medical Center, Dallas, Texas, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Hart LL; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, FL, USA; Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: llhart@wakehealth.edu.; Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.; Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA.; Campone M; Institut de Cancérologie de l'Ouest/René Gauducheau Centre de Recherche en Cancérologie, St. Herblain, France.; Pluard T; Saint Luke's Cancer Institute, Kansas City, MO, USA.; Sousa B; Breast Unit, Champalimaud Clinical and Research Center/Champalimaud Foundation, Lisbon, Portugal.; Freyer G; Oncology Department, Hôpital Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL) and Université de Lyon, France.; Decker T; Gemeinschaftspraxis für Hämatologie und Onkologie Ravensburg, Germany.; Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, GA, USA.; Sopher G; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Gao M; Novartis Pharma AG, Basel, Switzerland.; Hu H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Kuemmel S; Department of Gynecology with Breast Unit, Charité Hospital Berlin, Germany; Interdisciplinary Breast Unit, Kliniken Essen Mitte, Essen, Germany.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Fuentes Bayne HE; Mayo Clinic, Rochester, MN.; Kasi PM; Weill Cornell Medicine, New York, NY.; Ma L; Biotheranostics, a Hologic Company, San Diego, CA.; Hart LL; Florida Cancer Specialist, Fort Myers, FL.; Wong J; Biotheranostics, a Hologic Company, San Diego, CA.; Spigel DR; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Schnabel CA; Biotheranostics, a Hologic Company, San Diego, CA.; Reeves JA; Florida Cancer Specialist, Fort Myers, FL.; Halfdanarson TR; Mayo Clinic, Rochester, MN.; Treuner K; Biotheranostics, a Hologic Company, San Diego, CA.; Greco FA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Ruddy KJ; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. ruddy.kathryn@mayo.edu.; Zheng Y; Dana-Farber Cancer Institute, Boston, USA.; Tayob N; Dana-Farber Cancer Institute, Boston, USA.; Hu J; Dana-Farber Cancer Institute, Boston, USA.; Dang CT; Memorial Sloan Kettering Cancer Center, New York, USA.; Yardley DA; Tennessee Oncology, Nashville, USA.; Isakoff SJ; Massachussetts General Hospital, Boston, USA.; Valero VV; MD Anderson Cancer Center, Houston, USA.; Faggen MG; Dana-Farber Cancer Institute, Boston, USA.; Mulvey TM; Massachussetts General Hospital, Boston, USA.; Bose R; Siteman Cancer Center, St. Louis, USA.; Sella T; Dana-Farber Cancer Institute, Boston, USA.; Weckstein DJ; New Hampshire Oncology and Hematology, Hooksett, USA.; Wolff AC; Johns Hopkins University, Baltimore, USA.; Reeder-Hayes KE; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Rugo HS; Diller Family Comprehensive Cancer Center, University of California San Francisco Helen, San Francisco, USA.; Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, USA.; Zuckerman DS; St. Luke's Mountain States Tumor Institute, Boise, USA.; Hart LL; Florida Cancer Specialists, Brandon, USA.; Gadi VK; University of Illinois At Chicago, Chicago, USA.; Constantine M; Dana-Farber Cancer Institute, Boston, USA.; Cheng KL; Northwell Health, New York, USA.; Briccetti FM; Dana-Farber Cancer Institute, Boston, USA.; Schneider BP; Indiana University School of Medicine, Indianapolis, USA.; Merrill Garrett A; Eastern Maine Medical Center, Bangor, USA.; Kelly Marcom P; Duke University, Durham, USA.; Albain KS; Loyola University Medical Center, Maywood, USA.; DeFusco PA; Hartford HealthCare Cancer Institute, Avon, USA.; Tung NM; Beth Israel Deaconess Medical Center, Boston, USA.; Ardman BM; Lowell General Hospital, Lowell, USA.; Nanda R; University of Chicago, Chicago, USA.; Jankowitz RC; Penn Medicine Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Pohlmann PR; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.; Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL, USA.; Liu MC; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Rosenberg S; Dana-Farber Cancer Institute, Boston, USA.; DeMeo MK; Dana-Farber Cancer Institute, Boston, USA.; Burstein HJ; Dana-Farber Cancer Institute, Boston, USA.; Winer EP; Dana-Farber Cancer Institute, Boston, USA.; Krop IE; Dana-Farber Cancer Institute, Boston, USA.; Partridge AH; Dana-Farber Cancer Institute, Boston, USA.; Tolaney SM; Dana-Farber Cancer Institute, Boston, USA.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Paoletti C; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Currently at EISAI, Inc., Woodcliff Lake, NJ, USA.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.; Niman SM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.; Dolce EM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Darga EP; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Liu MC; Department of Oncology, Division of Medical Oncology, and Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.; Marcom PK; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA.; Hart LL; Florida Cancer Specialists/Wake Forest School of Medicine, Fort Myers, FL, USA.; Smith JW 2nd; US Oncology Research, Compass Oncology, Portland, OR, USA.; Tedesco KL; New York Oncology Hematology, US Oncology Network, Albany, NY, USA.; Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Krop IE; Department of Medical Oncology, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; DeMichele AM; Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA.; Goodwin PJ; Department of Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada.; Block M; Nebraska Cancer Specialists, Omaha, NE, USA.; Aung K; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Brown ME; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; McCormack RT; Janssen Pharmaceuticals, Inc., Raritan, NJ, USA.; Hayes DF; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA. hayesdf@umich.edu.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Berdeja JG; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Nashville, Tennessee.; Gregory TK; Sarah Cannon Research Institute, Nashville, Tennessee.; Colorado Blood Cancer Institute, Denver, Colorado.; Faber EA; Sarah Cannon Research Institute, Nashville, Tennessee.; Oncology Hematology Care, Cincinnati, Ohio.; Hart LL; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists, Fort Myers, Florida.; Mace JR; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists, St. Petersburg, Florida.; Arrowsmith ER; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Chattanooga, Tennessee.; Flinn IW; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Nashville, Tennessee.; Matous JV; Sarah Cannon Research Institute, Nashville, Tennessee.; Colorado Blood Cancer Institute, Denver, Colorado.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
Hart LL; Medical Oncology, Florida Cancer Specialists, Fort Myers, FL, USA. lhart@flcancer.com.; Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. lhart@flcancer.com.; Ferrarotto R; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andric ZG; Medical Oncology Department, Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia.; Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology Group, Rogers, MI, USA.; Subramanian J; Department of Medicine, Saint Luke's Hospital, Kansas City, MO, USA.; Radosavljevic DZ; Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.; Zaric B; Faculty of Medicine, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad, Sremska Kamenica, Serbia.; Hanna WT; Hematology/Oncology, University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.; Aljumaily R; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.; Sarah Cannon Research Institute, Nashville, TN, USA.; Owonikoko TK; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Verhoeven D; Department of Medical Oncology, AZ Klina Brasschaat, University of Antwerp, Antwerp, Belgium.; Xiao J; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.; Morris SR; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.; Antal JM; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.; Hussein MA; Department of Oncology, Florida Cancer Specialists, Leesburg, FL, USA.
Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Academic Journal
Mahalingam D; University of Texas Health Science Center, San Antonio, TX, USA.; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Patel MR; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL, USA.; Sachdev JC; HonorHealth Research Institute/Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA.; Hart LL; Florida Cancer Specialists, Fort Myers, FL, USA.; Halama N; National Center for Tumor Diseases, University Medical Center Heidelberg, Heidelberg, Germany.; Ramanathan RK; Mayo Clinic, Scottsdale, AZ, USA.; Sarantopoulos J; Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.; Völkel D; Baxalta Innovations GmbH a member of the Takeda group of companies, Vienna, Austria.; Youssef A; Baxalta US Inc. a member of the Takeda group of companies, Cambridge, MA, USA.; de Jong FA; Shire International GmbH, a Takeda company, Zug, Switzerland.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pavlick AC; Department of Medical Oncology, New York University School of Medicine, New York, New York.; Johnson DB; Department of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Hart LL; Florida Cancer Specialists and Research Institute, Fort Myers, Florida.; Infante JR; Tennessee Oncology, PLLC, Nashville, Tennessee.; Luke JJ; Department of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois.; Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida.; Rothschild NE; Florida Cancer Specialists, West Palm Beach, Florida.; Spitler LE; St. Mary's Medical Center, San Francisco, California.; Cowey CL; Northern California Melanoma Center, Baylor University Medical Center, Dallas, Texas.; Alizadeh AR; Northside Hospital Cancer Institute, Decatur, Georgia.; Salama AK; Department of Medical Oncology, Duke University, Durham, North Carolina.; He Y; Celldex Therapeutics, Inc, Hampton, New Jersey.; Hawthorne TR; Celldex Therapeutics, Inc, Hampton, New Jersey.; Bagley RG; Celldex Therapeutics, Inc, Hampton, New Jersey.; Zhang J; Celldex Therapeutics, Inc, Hampton, New Jersey.; Turner CD; Celldex Therapeutics, Inc, Hampton, New Jersey.; Hamid O; The Angeles Clinic and Research Institute, Los Angeles, California.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Grivas P; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.; Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Picus J; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, Missouri.; Hahn NM; Departments of Oncology and Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Milowsky MI; Department of Medicine, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Hart LL; Florida Cancer Specialists, Fort Myers, Florida.; Alva A; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.; Bellmunt J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pal SK; Department of Medical Oncology, City of Hope, Duarte, California.; Bambury RM; Department of Medical Oncology, Cork University Hospital, Cork, Ireland.; O'Donnell PH; Department of Medicine, University of Chicago, Chicago, Illinois.; Gupta S; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Guancial EA; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, New York.; Sonpavde GP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Faltaos D; Clinical Pharmacology, Mirati Therapeutics Inc, San Diego, California.; Potvin D; Biostatistics and Data Management, Mirati Therapeutics Inc, San Diego, California.; Christensen JG; Research, Mirati Therapeutics Inc, San Diego, California.; Chao RC; Clinical Development, Mirati Therapeutics Inc, San Diego, California.; Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Yardley DA; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN. Electronic address: dyardley@tnonc.com.; Hart LL; Sarah Cannon Research Institute, Nashville, TN; Florida Cancer Specialists, Fort Myers, FL.; Ward PJ; Oncology Hematology Care, Cincinnati, OH.; Wright GL; Sarah Cannon Research Institute, Nashville, TN; Florida Cancer Specialists, Fort Myers, FL.; Shastry M; Sarah Cannon Research Institute, Nashville, TN.; Finney L; Sarah Cannon Research Institute, Nashville, TN.; DeBusk LM; Sarah Cannon Research Institute, Nashville, TN.; Hainsworth JD; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN.
Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Academic Journal
O'Shaughnessy J; Texas Oncology-Baylor Charles A. Sammons Cancer Center and US Oncology Network, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. Joyce.OShaughnessy@USOncology.com.; Petrakova K; Masaryk Memorial Cancer Institute, Žlutý kopec 543/7, 656 53, Brno, Czech Republic.; Sonke GS; Netherlands Cancer Institute and BOOG Study Center, IJsbaanpad 9, 1076 CV, Amsterdam, The Netherlands.; Conte P; University of Padova and Istituto Oncologico Veneto, IRCCS, Via Gattamelata, 64, Padua, Italy.; Arteaga CL; Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA.; Cameron DA; Edinburgh Cancer Centre, University of Edinburgh, Crewe Rd S, Edinburgh, EH4 2XR, UK.; Hart LL; Sarah Cannon Research Institute, Fort Myers, FL, 33916, USA.; Villanueva C; University Hospital of Besançon, Jean-Minjoz University Hospital, 3 Boulevard Alexandre Fleming, 25000, Besançon, France.; Jakobsen E; Lillebaelt Hospital, Kabbeltoft 25, 7100, Vejle, Denmark.; Beck JT; Highlands Oncology Group, 3232 N Northhills Blvd, Fayetteville, AR, 72703, USA.; Lindquist D; Arizona Oncology, US Oncology Network, 3700 W State Rte 89A, Sedona, AZ, 86336, USA.; Souami F; Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland.; Mondal S; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA.; Germa C; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA.; Hortobagyi GN; University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA jbendell@tnonc.com.; Hochster H; Yale School of Medicine, New Haven, Connecticut, USA.; Hart LL; Sarah Cannon Research Institute/Florida Cancer Specialists, Fort Myers, Florida, USA.; Firdaus I; Sarah Cannon Research Institute/Oncology Hematology Care, Cincinnati, Ohio, USA.; Mace JR; Sarah Cannon Research Institute/Florida Cancer Specialists, St Petersburg, Florida, USA.; McFarlane JJ; Sarah Cannon Research Institute/Virginia Cancer Institute, Richmond, Virginia, USA.; Kozloff M; University of Chicago, Chicago, Illinois, USA.; Catenacci D; University of Chicago, Chicago, Illinois, USA.; Hsu JJ; Genentech Inc., South San Francisco, California, USA.; Hack SP; Genentech Inc., South San Francisco, California, USA.; Shames DS; Genentech Inc., South San Francisco, California, USA.; Phan SC; Genentech Inc., South San Francisco, California, USA.; Koeppen H; Genentech Inc., South San Francisco, California, USA.; Cohn AL; Rocky Mountain Cancer Center, Denver, Colorado, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Eng C; The University of Texas M.D. Anderson Cancer Center, Houston, TX.; Bessudo A; cCARE (California Cancer Associates for Research & Excellence), Encinitas, CA.; Hart LL; Florida Cancer Specialists/Sarah Cannon Research Institute, Fort Myers, FL.; Severtsev A; The Central Clinical Hospital #1, Moscow, Russia.; Gladkov O; Chelyabinsk Regional Clinical Oncological Dispensary, Chelyabinsk, Russia.; Müller L; Onkologie Untere Ems Leer-Emden-Papenburg, Leer, Germany.; Kopp MV; Samara Regional Clinical Oncology Dispensary, Samara, Russia.; Vladimirov V; Pyatigorsk Oncological Dispensary, Pyatigorsk, Russia.; Langdon R; Nebraska Methodist Hospital Cancer Center, Omaha, NE.; Kotiv B; Military Medical Academy, Saint Petersburg, Russia.; Barni S; Azienda Ospedaliera Treviglio, Treviglio, BG, Italy.; Hsu C; Daiichi Sankyo, Inc, Edison, NJ.; Bolotin E; Bayer HealthCare, Whippany, NJ, (Employed at Daiichi Sankyo, Inc. At Time of Manuscript Preparation).; von Roemeling R; Daiichi Sankyo, Inc, Edison, NJ.; Schwartz B; ArQule, Inc, Burlington, MA.; Bendell JC; Tennessee Oncology/Sarah Cannon Research Institute, Nashville, TN.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Suite 110, 250 25th Avenue North, Nashville, TN, 37203, USA, jbendell@tnonc.com.; Lenz HJRyan TEl-Rayes BFMarshall JLModiano MRHart LLKingsley CDGeorge TJNakashima DBerlin JD
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Gnant M; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. michael.gnant@meduniwien.ac.at; Baselga JRugo HSNoguchi SBurris HAPiccart MHortobagyi GNEakle JMukai HIwata HGeberth MHart LLHadji PEl-Hashimy MRao STaran TSahmoud TLebwohl DCampone MPritchard KI
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Hart, Lowell L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어